Sanofi: finalises acquisition of Abllynx
(CercleFinance.com) - Sanofi has announced that it has now acquired all of the shares (including those represented by American Depositary Shares), warrants and convertible bonds outstanding at the end of its takeover procedure.
On 12 June, 2,893,201 Ablynx shares and eight convertible bonds were tendered to the offer. These securities tendered over the period of the offer should be settled on or around 19 June.
On 13 June, shares, ADS and convertible bonds were withdrawn from the listing. All shares and convertible debentures that have not been made during the takeover offer are set to be automatically transferred to Sanofi.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
On 12 June, 2,893,201 Ablynx shares and eight convertible bonds were tendered to the offer. These securities tendered over the period of the offer should be settled on or around 19 June.
On 13 June, shares, ADS and convertible bonds were withdrawn from the listing. All shares and convertible debentures that have not been made during the takeover offer are set to be automatically transferred to Sanofi.
Copyright (c) 2018 CercleFinance.com. All rights reserved.